Phenotype
|
Fish
|
Conditions
|
Figures
|
retina ccnd1 expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
whole organism baxa expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina mitotic spindle morphology, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 4
from Li et al., 2021
|
whole organism dead, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
text only
from Li et al., 2021
|
head rad51b expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
retina layer formation disrupted, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure S3
from Li et al., 2021
|
head rtel1 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
glial cell differentiation disrupted, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure S4
from Li et al., 2021
|
whole organism ccng1 expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina structure, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure S3
from Li et al., 2021
|
whole organism tp53 expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
head rad17 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
whole organism cdkn1a expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
multi fate stem cell mitotic spindle morphology, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 4
from Li et al., 2021
|
retina disorganized, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure S3
from Li et al., 2021
|
head rad9a expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
whole organism bbc3 expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina mitotic M phase temporally extended, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 4
from Li et al., 2021
|
whole organism mdm2 expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina Ab11-sox2 labeling increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
eye photoreceptor cell zpr-3 labeling decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
brain apoptotic process increased occurrence, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
head Ab1-mlh1 labeling decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
retina mitotic cell cycle process quality, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 4
from Li et al., 2021
|
eye decreased size, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 1
from Li et al., 2021
|
whole organism decreased length, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 1
from Li et al., 2021
|
retina vsx2 expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
retina has fewer parts of type neuron, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
head Ab1-prpf31 labeling decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 1 ,
Figure 5
from Li et al., 2021
|
head sfi1 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
head prpf31 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 1
from Li et al., 2021
|
head ab13-tp53 labeling increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 5
from Li et al., 2021
|
retina ab2-h2afx labeling increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 5
from Li et al., 2021
|
neural retina development disrupted, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2 ,
Figure 3 ,
Figure S4
from Li et al., 2021
|
whole organism casp8 expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
regulation of alternative mRNA splicing, via spliceosome disrupted, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 5 ,
Figure 7
from Li et al., 2021
|
whole organism bcl2a expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina multi fate stem cell Ab11-sox2 labeling spatial pattern, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
retina chromatin structure, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure S7
from Li et al., 2021
|
retina atoh7 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
whole organism increased curvature, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 1
from Li et al., 2021
|
retina crx expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
spinal cord apoptotic process increased occurrence, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
head Ab1-rtel1 labeling decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
head ska1 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
retina neurod1 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
whole organism gadd45ba expression increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
head mlh1 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
retina mitotic cell cycle arrested, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 4
from Li et al., 2021
|
retina apoptotic process increased occurrence, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3 ,
Figure S7
from Li et al., 2021
|
retina site of DNA damage increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 5
from Li et al., 2021
|
retina nucleus condensed, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure S3
from Li et al., 2021
|
head lrrcc1 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
head ab2-h2afx labeling increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 5
from Li et al., 2021
|
retina has extra parts of type multi fate stem cell, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2 ,
Figure 3
from Li et al., 2021
|
retinal inner nuclear layer Ab6-isl1 labeling decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
head decreased size, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 1
from Li et al., 2021
|
head kifc1 expression decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 7
from Li et al., 2021
|
retina Ab6-isl1 labeling decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina multi fate stem cell Ab11-sox2 labeling increased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
eye photoreceptor cell zpr-1 labeling decreased amount, abnormal
|
prpf31hzu12/hzu12
|
standard conditions
|
Figure 2
from Li et al., 2021
|
retina neuron EGFP expression decreased amount, abnormal
|
prpf31hzu12/hzu12; knu3Tg
|
standard conditions
|
Figure 2
from Li et al., 2021
|
retina neuron EGFP expression decreased amount, abnormal
|
prpf31hzu12/hzu12; nl1Tg
|
standard conditions
|
Figure 2
from Li et al., 2021
|
neural retina development disrupted, abnormal
|
prpf31hzu12/hzu12; tp53ihb135/ihb135
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina has extra parts of type multi fate stem cell, abnormal
|
prpf31hzu12/hzu12; tp53ihb135/ihb135
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina Ab6-isl1 labeling decreased amount, abnormal
|
prpf31hzu12/hzu12; tp53ihb135/ihb135
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina apoptotic process occurrence, ameliorated
|
prpf31hzu12/hzu12; tp53ihb135/ihb135
|
standard conditions
|
Figure 3
from Li et al., 2021
|
retina Ab11-sox2 labeling increased amount, abnormal
|
prpf31hzu12/hzu12; tp53ihb135/ihb135
|
standard conditions
|
Figure 3
from Li et al., 2021
|